The Emerging Role of Oxaloacetate in Tumor Metabolic Reprogramming: Mechanisms and Translational Perspectives
Cancer Bioscience · 2026
DOI: 10.1016/j.cbs.2026.100011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Bioscience, 2026. Verfasst von Zeyu Miao und 7 weiteren Autor:innen. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Oxaloacetate (OAA), traditionally recognized as a central intermediate of the tricarboxylic acid cycle and a key precursor in gluconeogenesis, is increasingly appreciated for functions that extend beyond its canonical metabolic roles. Emerging evidence suggests a potential role for OAA in modulating cellular metabolism and signaling, particularly in the context of tumor metabolic reprogramming. In this review, we first summarize the established metabolic pathways involving OAA under physiological conditions, followed by an examination of its neuroprotective effects in cerebral ischemia and related disorders, with emphasis on its roles in glutamate clearance and mitochondrial biogenesis. We then discuss recent findings in oncology, highlighting OAA as a potential modulator of glucose metabolism that may influence the Warburg phenotype and promote apoptosis in metabolically susceptible tumor cells, including those with elevated c-Myc activity. Furthermore, OAA is considered within the broader landscape of metabolite-driven cancer therapeutics through comparison with other key intermediates, including acetyl-CoA, malate, citrate, and lactate. Collectively, these insights support a revised view of OAA as a metabolite with metabolic functions and potential regulatory properties and suggest its potential relevance for therapeutic development, while also underscoring the need for further mechanistic and translational studies.
Zitieren
APA
Miao, Z., Hu, M., Li, K., Liu, J., Lin, W., Xiong, W., Zhang, H., & Zhang, Y. (2026). The Emerging Role of Oxaloacetate in Tumor Metabolic Reprogramming: Mechanisms and Translational Perspectives. Cancer Bioscience. https://doi.org/10.1016/j.cbs.2026.100011
Vancouver
Miao Z, Hu M, Li K, Liu J, Lin W, Xiong W, et al. The Emerging Role of Oxaloacetate in Tumor Metabolic Reprogramming: Mechanisms and Translational Perspectives. Cancer Bioscience. 2026. doi:10.1016/j.cbs.2026.100011
BibTeX
@article{Miao2026,
author = {Miao, Zeyu and Hu, Mengyuan and Li, Kaixia and Liu, Jinhua and Lin, Weihua and Xiong, Wei and Zhang, Hao and Zhang, Yiqiang},
title = {The Emerging Role of Oxaloacetate in Tumor Metabolic Reprogramming: Mechanisms and Translational Perspectives},
journal = {Cancer Bioscience},
year = {2026},
doi = {10.1016/j.cbs.2026.100011}
}
EUVIMED